Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hyperandrogenism × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 9 Nausea 7 Multiple Myeloma 7 Leukemia 7 Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma 4 Immunoglobulin Light-chain Amyloidosis 4 Breast Neoplasms 4 Polycystic Ovary Syndrome 3 Lymphoma, Follicular 3 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sezary Syndrome 2 Sarcoma 2 Prostatic Neoplasms 2 Primary Myelofibrosis 2 Postoperative Nausea and Vomiting 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Ovarian Neoplasms 2 Obesity 2 Neuroblastoma 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Metformin 3 Progesterone 2 Inositol 2 Folic Acid 2 bicalutamide 1 Yoga 1 Thioctic Acid 1 Spironolactone 1 Phlebotomy 1 Ovidrel 1 Magnesium 1 Lactalbumin 1 Flutamide 1 Ethinyl Estradiol 1 Estradiol 1 Dexamethasone 1 Cyproterone Acetate 1 Carnitine 1 Bloodletting 1 Blood Donation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡